IL17A and rheumatoid arthritis: Research has indicated that XFC can inhibit RA-specific FLS (RA-FLS) proliferation, regulate inflammatory factors and oxidative stress, reduce IL-6 and IL-17 levels, and enhance Nrf2, HO-1 expressions (34).